Safer Chemicals
ID: 6Type: Phase I
Overview

Topic

Safer Chemicals

Agency

Environmental Protection AgencyN/A

Program

Type: SBIRPhase: Phase IYear: 2023

Topic Link

https://www.sbir.gov/node/2424615

Additional Information

https://www.epa.gov/sbir/sbir-funding-opportunities
Timeline
  1. 1
    Release Jun 28, 2023 12:00 AM
  2. 2
    Open Jun 28, 2023 12:00 AM
  3. 3
    Next Submission Due Aug 23, 2023 12:00 AM
  4. 4
    Close Aug 23, 2023 12:00 AM
Description

The Environmental Protection Agency (EPA) is seeking proposals for the topic of "Safer Chemicals" in their SBIR Phase I solicitation for the year 2023. The solicitation was released on June 28, 2023, and the application deadline was on August 23, 2023. The EPA is interested in research projects that focus on developing technologies or solutions to promote the use of safer chemicals. The goal is to reduce the environmental and human health impacts associated with chemical substances. The solicitation is open to various fields and the project duration and funding specifics can be found on the EPA SBIR website.

Files
No associated files provided.
Similar Opportunities
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Phase II applications, including Fast-Track applications. The application due date is March 13th of each year, starting in 2024. For more information, visit the [solicitation link](https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-048.html).
DOD SBIR 24.4 Annual - Innovative Solutions for Ethylene Oxide Mitigation Used in Sterilization Processes (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for innovative solutions to mitigate ethylene oxide (ETO) used in sterilization processes. The goal is to promote environmentally friendly and sustainable practices in the field of sterilization technologies. ETO is commonly used in the manufacturing of medical devices for its effective sterilization properties, but its use raises environmental and health concerns due to its potential carcinogenicity. The DOD is specifically looking for advancements in sterilization technologies that prioritize environmental sustainability and health by minimizing or eliminating ethylene oxide emissions during medical device sterilization. The technology should be compatible with current ETO sterilization equipment and processes, and should not require significant alterations to existing setups. The proposal should include a plan for FDA clearance and EPA review, and the technology should be operable with little training or background. The project will have a Phase I feasibility study followed by a Phase II development and refinement of the solution. The Phase II focus includes prototype development, efficacy testing, regulatory compliance, and a scale-up strategy or commercialization plan. The ultimate goal is to transition the ETO mitigation solution into widespread implementation across diverse industries, including medical, pharmaceutical, food, laboratory, veterinary, cosmetic, and textile sectors. The small business should have plans to secure funding from non-SBIR government sources and/or the private sector to develop or transition the prototypes into a viable product for sale to the military and/or commercial markets. The successful implementation of the ETO mitigation solution will contribute to a safer and more sustainable future for medical device manufacturing.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The purpose of this funding opportunity is to support small business concerns in developing technologies for commercialization that can fill the service gaps in addressing SUD. The research objectives include developing products that reduce costs, time, and increase access in addressing health-related social needs such as housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The technologies can include physical devices, digital services, software, or non-physical/non-tangible products. The funding opportunity is open for applications until March 14, 2026, and offers both Phase I and Phase II funding options. Phase I focuses on establishing technical merit and feasibility, while Phase II aims to advance technologies towards commercialization. Applicants are encouraged to review the guidelines and adhere to the requirements applicable to their research.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Fast-Track (Phase I/Phase II) applications, with a focus on establishing technical feasibility and commercial potential. The application due date is March 13th, 2024, with subsequent due dates in 2025 and 2026. More information can be found on the grants.gov website.
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. The focus of this solicitation is on improving pain measurement and treatment. The goal is to address the national opioid public health crisis by providing scientific solutions for chronic pain, which affects over 25 million Americans. The research objectives include enhancing pain management through the development of new screening tools, models, and therapies, as well as advancing non-addictive pain analgesic treatments and improving pain management strategies for acute and chronic pain conditions. The solicitation is open for applications until April 5, 2025, and interested applicants can find more information on the grants.gov website.